Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study

NCT04954235 is registered in ClinicalTrials.gov with Inmunova S.A. as lead sponsor.

NCT NCT04954235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04954235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study
Lead sponsor
Inmunova S.A.
Phase
Observational
Overall status
Completed
Start date
May 22, 2021
Completion date
September 9, 2021
Enrollment
847 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19